103 related articles for article (PubMed ID: 15033491)
21. Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF.
Nandi AK; Rapoport AP
Leuk Res; 2006 Apr; 30(4):437-47. PubMed ID: 16171862
[TBL] [Abstract][Full Text] [Related]
22. Comparative genomics on MCM8 orthologous genes reveals the transcriptional regulation by transcription factor E2F.
Hayashi R; Goto Y; Haga A; Kobayashi D; Ikeda R; Yoshida K
Gene; 2006 Feb; 367():126-34. PubMed ID: 16325355
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of AKT activation by E2F.
Chaussepied M; Ginsberg D
Mol Cell; 2004 Dec; 16(5):831-7. PubMed ID: 15574337
[TBL] [Abstract][Full Text] [Related]
24. The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis.
Chapard C; Hohl D; Huber M
Oncotarget; 2015 Aug; 6(25):20933-45. PubMed ID: 26369285
[TBL] [Abstract][Full Text] [Related]
25. Identification and functional analysis of a CDE/CHR element in the POLD1 promoter.
SONG N; ZHU X; SHI L; AN J; WU Y; SANG J
Sci China C Life Sci; 2009 Jun; 52(6):551-9. PubMed ID: 19557333
[TBL] [Abstract][Full Text] [Related]
26. A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites.
Haugwitz U; Wasner M; Wiedmann M; Spiesbach K; Rother K; Mössner J; Engeland K
Nucleic Acids Res; 2002 May; 30(9):1967-76. PubMed ID: 11972334
[TBL] [Abstract][Full Text] [Related]
27. S Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region.
Chabes AL; Björklund S; Thelander L
J Biol Chem; 2004 Mar; 279(11):10796-807. PubMed ID: 14688249
[TBL] [Abstract][Full Text] [Related]
28. EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.
Novy M; Pohn R; Andorfer P; Novy-Weiland T; Galos B; Schwarzmayr L; Rotheneder H
Mol Biol Cell; 2005 May; 16(5):2181-90. PubMed ID: 15716352
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP.
Park KK; Deok Ahn J; Lee IK; Magae J; Heintz NH; Kwak JY; Lee YC; Cho YS; Kim HC; Chae YM; Ho Kim Y; Kim CH; Chang YC
Biochem Biophys Res Commun; 2003 Sep; 308(4):689-97. PubMed ID: 12927774
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of novel isoforms of human DP-1: DP-1{alpha} regulates the transcriptional activity of E2F1 as well as cell cycle progression in a dominant-negative manner.
Ishida H; Masuhiro Y; Fukushima A; Argueta JG; Yamaguchi N; Shiota S; Hanazawa S
J Biol Chem; 2005 Jul; 280(26):24642-8. PubMed ID: 15863509
[TBL] [Abstract][Full Text] [Related]
31. Use of chromatin immunoprecipitation to clone novel E2F target promoters.
Weinmann AS; Bartley SM; Zhang T; Zhang MQ; Farnham PJ
Mol Cell Biol; 2001 Oct; 21(20):6820-32. PubMed ID: 11564866
[TBL] [Abstract][Full Text] [Related]
32. An E2F site in the 5'-promoter region contributes to serum-dependent up-regulation of the human proliferating cell nuclear antigen gene.
Li YY; Wang L; Lu CD
FEBS Lett; 2003 Jun; 544(1-3):112-8. PubMed ID: 12782299
[TBL] [Abstract][Full Text] [Related]
33. Development of pyrrole-imidazole polyamide for specific regulation of human aurora kinase-A and -B gene expression.
Takahashi T; Asami Y; Kitamura E; Suzuki T; Wang X; Igarashi J; Morohashi A; Shinojima Y; Kanou H; Saito K; Takasu T; Nagase H; Harada Y; Kuroda K; Watanabe T; Kumamoto S; Aoyama T; Matsumoto Y; Bando T; Sugiyama H; Yoshida-Noro C; Fukuda N; Hayashi N
Chem Biol; 2008 Aug; 15(8):829-41. PubMed ID: 18721754
[TBL] [Abstract][Full Text] [Related]
34. CHF: a novel factor binding to cyclin A CHR corepressor element.
Philips A; Chambeyron S; Lamb N; Vié A; Blanchard JM
Oncogene; 1999 Nov; 18(46):6222-32. PubMed ID: 10597220
[TBL] [Abstract][Full Text] [Related]
35. Low concentration of arsenic-induced aberrant mitosis in keratinocytes through E2F1 transcriptionally regulated Aurora-A.
Wu CH; Tseng YS; Kao YT; Sheu HM; Liu HS
Toxicol Sci; 2013 Mar; 132(1):43-52. PubMed ID: 23174854
[TBL] [Abstract][Full Text] [Related]
36. Proliferation-dependent expression of nuclear uracil-DNA glycosylase is mediated in part by E2F-4.
Muller-Weeks S; Balzer RJ; Anderson R; Caradonna S
DNA Repair (Amst); 2005 Feb; 4(2):183-90. PubMed ID: 15590326
[TBL] [Abstract][Full Text] [Related]
37. E2Ls, E2F-like repressors of Arabidopsis that bind to E2F sites in a monomeric form.
Kosugi S; Ohashi Y
J Biol Chem; 2002 May; 277(19):16553-8. PubMed ID: 11867638
[TBL] [Abstract][Full Text] [Related]
38. Timing of transcription during the cell cycle: Protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression.
Müller GA; Stangner K; Schmitt T; Wintsche A; Engeland K
Oncotarget; 2017 Nov; 8(58):97736-97748. PubMed ID: 29228647
[TBL] [Abstract][Full Text] [Related]
39. Cell cycle regulation of the human polo-like kinase (PLK) promoter.
Uchiumi T; Longo DL; Ferris DK
J Biol Chem; 1997 Apr; 272(14):9166-74. PubMed ID: 9083047
[TBL] [Abstract][Full Text] [Related]
40. Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.
Fischer M; Quaas M; Wintsche A; Müller GA; Engeland K
Nucleic Acids Res; 2014 Jan; 42(1):163-80. PubMed ID: 24071582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
